Skip navigation
Speakers

Strategies to Effectively Scale the Business and Best Practices for Accounting and Reporting

September 25-26, 2018
  • Boston, MA

Nancy Aubrey
Risk Advisory Services, Life Sciences Industry
RSM US LLP

Robert Auslander
Vice President Technical Accounting and Policy
Valeant Pharmaceuticals

Sima Basher
Associate Director,
Corporate Consolidation & Financial Reporting
Bristol-Myers Squibb

Sabrina Basu
Director, External Reporting,
Technical Accounting and Internal Controls
Ironwood Pharmaceuticals

Marc Belsky
Chief Financial Officer
Kezar Life Sciences

Dan Carlson
Consultant, Accounting and Financial Reporting
Eli Lilly & Co

Amy Diebler
Vice President, Finance and Chief Financial Officer
Chiesi USA Inc.

Gisele Dion
Group Vice President, Corporate Controller
Shire

Ryan Dolan
Partner, Co-Leader of Life Sciences Practice
CFGI

Nancy Dong
Vice President, Finance & Administration
ContraFect Corp.

Kim Cobleigh Drapkin
Chief Financial Officer
Jounce Therapeutics, Inc.

Peter Emerling
Director, Technology and Management Consulting
RSM US LLP

Stephen Garbacz
Senior Vice President of Finance and Operations
Spero Therapeutics

Mike Gregorski
Partner, National Director of Risk -
Technical Accounting Consulting
RSM US LLP

John Lanza
National Life Sciences Industry Leader
RSM US LLP

Chris Lindblom
Vice President, Finance and Operations
Warp Drive Bio

Kelly MacDonald
Senior Director, Financial Planning & Analysis
Ironwood Pharmaceuticals

Ted Myles
Executive Vice President and Chief Financial Officer
AMAG Pharmaceuticals

Federica "Freddi" O'Brien
President
CFO'Brien Consulting, LLC
former CFO
Barrier Therapeutics, Cardiokine Inc., Cervilenz Inc.,
Cerecor Inc., Complexa Inc.

Daphne Quimi
Senior Vice President –
Finance and Administration, Corporate Controller
Amicus Therapeutics Inc.

William T. Roberts
Partner, Americas Financial Accounting Advisory Services
Ernst & Young LLP

Michelle Ross
North America Head of Finance
Guerbet LLC

Ryan Udell
Partner and Co-Chair, Corporate and Securities Group
White and Williams LLP

Kory Wentworth
Vice President, Finance and Principal Accounting Officer
bluebird bio

Nancy Aubrey
Risk Advisory Services, Life Sciences Industry
RSM US LLP

Robert Auslander
Vice President Technical Accounting and Policy
Valeant Pharmaceuticals

Sima Basher
Associate Director,
Corporate Consolidation & Financial Reporting
Bristol-Myers Squibb

Sabrina Basu
Director, External Reporting,
Technical Accounting and Internal Controls
Ironwood Pharmaceuticals

Marc Belsky
Chief Financial Officer
Kezar Life Sciences

Dan Carlson
Consultant, Accounting and Financial Reporting
Eli Lilly & Co

Amy Diebler
Vice President, Finance and Chief Financial Officer
Chiesi USA Inc.

Gisele Dion
Group Vice President, Corporate Controller
Shire

Ryan Dolan
Partner, Co-Leader of Life Sciences Practice
CFGI

Nancy Dong
Vice President, Finance & Administration
ContraFect Corp.

Kim Cobleigh Drapkin
Chief Financial Officer
Jounce Therapeutics, Inc.

Peter Emerling
Director, Technology and Management Consulting
RSM US LLP

Stephen Garbacz
Senior Vice President of Finance and Operations
Spero Therapeutics

Mike Gregorski
Partner, National Director of Risk -
Technical Accounting Consulting
RSM US LLP

John Lanza
National Life Sciences Industry Leader
RSM US LLP

Chris Lindblom
Vice President, Finance and Operations
Warp Drive Bio

Kelly MacDonald
Senior Director, Financial Planning & Analysis
Ironwood Pharmaceuticals

Ted Myles
Executive Vice President and Chief Financial Officer
AMAG Pharmaceuticals

Federica "Freddi" O'Brien
President
CFO'Brien Consulting, LLC
former CFO
Barrier Therapeutics, Cardiokine Inc., Cervilenz Inc.,
Cerecor Inc., Complexa Inc.

Daphne Quimi
Senior Vice President –
Finance and Administration, Corporate Controller
Amicus Therapeutics Inc.

William T. Roberts
Partner, Americas Financial Accounting Advisory Services
Ernst & Young LLP

Michelle Ross
North America Head of Finance
Guerbet LLC

Ryan Udell
Partner and Co-Chair, Corporate and Securities Group
White and Williams LLP

Kory Wentworth
Vice President, Finance and Principal Accounting Officer
bluebird bio